DeepMind takes a major step forward in understanding proteins

London – DeepMind, the UK-based artificial intelligence (AI) company owned by Alphabet, said it could predict the structure of proteins, a step forward that could greatly accelerate the discovery of new drugs.

Scientists have spent decades trying to understand how proteins, which start out as strings of chemical compounds, fold into three-dimensional shapes, which then define their behavior …